Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-16

Clinical Trial Update: Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating whether a Sevoflurane with Dexmedetomidine regimen reduces emergence delirium compared with Isoflurane.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Sevoflurane (Sevoflurane)
  • isoflurane (isoflurane)

Snippet

Sponsor: Mayo Clinic | Conditions: Delirium on Emergence | Phase 3 | Status: RECRUITING